Clin Infect Dis: A randomized clinical trial of high-dose rifampicin with or without levofloxacin
Lancet Oncol: 10-year follow-up results of high-dose radiotherapy plus long-term androgen deprivation therapy for prostate cancer
JAMA Oncology: High-dose radiotherapy for high-risk prostate cancer, what is the optimal duration of ADT?
NEJM: A single high-dose liposomal regimen of amphotericin B for HIV-associated cryptococcal meningitis
Taking high-dose vitamin D supplements for 5 years did not affect cardiovascular disease or cancer rates
PPT Sharing Professor Chen Shi: Is a high-dose dexamethasone suppression test necessary?
Shanghai Ruijin Hospital reported: How high is the neutralizing titer of serum Omicron after the third dose of inactivated vaccine?
Amoxicillin in the treatment of childhood pneumonia, low-dose or high-dose, short-term or long-term?
Clin Cancer Res: Efficacy of high-dose IL-2 combined with stereotactic ablation radiotherapy in the treatment of metastatic renal cell carcinoma
LEUKEMIA: Bortezomib-based induction, high-dose melphalan and lenalidomide maintenance treatment for myeloma up to 70 years old
Studies by many universities have found that high-dose intensive treatment is better for children with cerebral palsy
[JAMA] Can patients with severe COVID-19 really benefit from high-dose corticosteroids?
Bortezomib induction, high-dose melphalan and lenalidomide maintenance treatment for myeloma patients under 70 years old
Lancet Haemat: All-trans retinoic acid + high-dose dexamethasone may become a new first-line therapy for primary immune thrombocytopenia!
Can high-dose vitamin C reduce the mortality of sepsis?
Nutr Metab: A powerful tool for improving the physical and mental health and immune status of breast cancer survivors: Yoga + high-dose vitamin D!
Blood Cancer J: High-dose methotrexate can effectively prevent isolated CNS recurrence in DLBCL patients
Clin Gastroenterology H: The use of high-dose vitamin D does not prevent the recurrence of Crohn's disease after surgery
Clin Cancer Res: Early use of high-dose hormones to manage irAE is associated with poor prognosis of anti-PD-1 monotherapy for advanced melanoma
Taiwan's high-end vaccine announced the data of the second phase test, the seroconversion rate of 28 days after the second dose reached 99.8%?